Article(id=1329869470555812124, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329869401546928487, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2023.01.004, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1669564800000, receivedDateStr=2022-11-28, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794995189559, onlineDateStr=2026-11-18, pubDate=1673280000000, pubDateStr=2023-01-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794995189559, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794995189559, creator=13701087609, updateTime=1794995189559, updator=13701087609, issue=Issue{id=1329869401546928487, tenantId=1146029695717560320, journalId=1319690329412173987, year='2023', volume='44', issue='1', pageStart='1', pageEnd='100', issueExtLink='null', onlineDate='null', pubDate='1673280000000', pubDateStr='2023-01-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794995173107, creator='13701087609', updateTime=1794995764620, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329871882981060993, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329869401546928487, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329871882981060994, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329869401546928487, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=19, endPage=26, ext={EN=ArticleExt(id=1329869470790693149, articleId=1329869470555812124, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Research progress on sodium-glucose linked transporter 2 inhibitors in the treatment of diabetic nephropathy, columnId=1325221107665612978, journalTitle=World Clinical Drug, columnName=Topic, runingTitle=null, highlight=null, articleAbstract=
Sodium-glucose linked transporter 2 inhibitor (SGLT-2i) is a new type of oral hypoglycemic agents. They can lower blood pressure, reduce uric acid, reduce body weight and reduce cardiac and renal adverse events by promoting urinary glucose and sodium excretion in renal tubules. SGLT-2i is one of the hot topics in the treatment of diabetes mellitus (DM) in recent years, which can effectively delay the progression of diabetic nephropathy (DN). This article reviewed the mechanism of action, clinical benefits, safety and guideline update of SGLT-2i in the treatment of DN, in order to provide new strategies for clinical treatment.
, authors=Bingbing ZHU
1, 2, Ying FAN
1, Niansong WANG
1, *, authorsList=Bingbing ZHU, Ying FAN, Niansong WANG, authorCompany=null, correspAuthors=Niansong WANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329869471067517214, articleId=1329869470555812124, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=钠-葡萄糖耦联转运体2抑制剂治疗糖尿病肾病研究进展, columnId=1325221107824996532, journalTitle=世界临床药物, columnName=医药专论, runingTitle=null, highlight=null, articleAbstract=
钠-葡萄糖耦联转运体2抑制剂(sodium-glucose linked transporter 2 inhibitor,SGLT-2i)是一种新型口服降糖药物,通过促进肾小管尿糖、尿钠排泄,发挥降糖、降血压、降尿酸、减轻体质量以及减少心肾不良事件等多重作用。SGLT-2i是近年来糖尿病(diabetes mellitus,DM)治疗领域的热点之一,可有效延缓DM肾病(diabetic nephropathy,DN)进展。现将综述SGLT-2i治疗DN的作用机制、临床获益、安全性及指南更新等,旨在为临床治疗工作提供新策略。
, authors=朱冰冰
1, 2, 范瑛
1, 汪年松
1, *, authorsList=朱冰冰, 范瑛, 汪年松, authorCompany=null, correspAuthors=汪年松, authorNote=
朱冰冰,副主任医师,研究方向:糖尿病肾脏疾病、慢性肾小管间质纤维化发病机制及中西医结合防治。
, correspAuthorsNote=
汪年松,主任医师,教授,博士研究生导师,研究方向:糖尿病肾脏疾病、急性肾损伤发病机制和防治。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=T2e1Zkfjv5Th1OD6PPHbFw==, magXml=GTxueLdFgwZELXE3odWJZw==, pdfUrl=null, pdf=jIzWlZKwOvGQHfhTtGJQUA==, pdfFileSize=1593853, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=VBX9rDZ6FzZTlyoEjUc68w==, mapNumber=null, fund=null)}, authors=[Author(id=1329869471428227366, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329869471495336233, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, authorId=1329869471428227366, language=EN, stringName=Bingbing ZHU, firstName=Bingbing, middleName=null, lastName=ZHU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, 2, address=
1.Department of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China
2.Department of Nephrology, Putuo Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329869471558250794, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, authorId=1329869471428227366, language=CN, stringName=朱冰冰, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, 2, address=
1.上海交通大学附属上海市第六人民医院肾脏内科,上海 200233
2.上海中医药大学附属普陀医院肾脏内科,上海 200062, bio={"content":"
朱冰冰,副主任医师,研究方向:糖尿病肾脏疾病、慢性肾小管间质纤维化发病机制及中西医结合防治。
"}, bioImg=null, bioContent=
朱冰冰,副主任医师,研究方向:糖尿病肾脏疾病、慢性肾小管间质纤维化发病机制及中西医结合防治。
, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329869471281426719, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, xref=1., ext=[AuthorCompanyExt(id=1329869471289815328, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, companyId=1329869471281426719, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.Department of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China), AuthorCompanyExt(id=1329869471298203937, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, companyId=1329869471281426719, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.上海交通大学附属上海市第六人民医院肾脏内科,上海 200233)]), AuthorCompany(id=1329869471356924194, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, xref=2., ext=[AuthorCompanyExt(id=1329869471365312803, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, companyId=1329869471356924194, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.Department of Nephrology, Putuo Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China), AuthorCompanyExt(id=1329869471373701412, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, companyId=1329869471356924194, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.上海中医药大学附属普陀医院肾脏内科,上海 200062)])]), Author(id=1329869471612776748, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329869471675691310, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, authorId=1329869471612776748, language=EN, stringName=Ying FAN, firstName=Ying, middleName=null, lastName=FAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, address=
1.Department of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329869471734411567, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, authorId=1329869471612776748, language=CN, stringName=范瑛, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, address=
1.上海交通大学附属上海市第六人民医院肾脏内科,上海 200233, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329869471281426719, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, xref=1., ext=[AuthorCompanyExt(id=1329869471289815328, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, companyId=1329869471281426719, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.Department of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China), AuthorCompanyExt(id=1329869471298203937, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, companyId=1329869471281426719, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.上海交通大学附属上海市第六人民医院肾脏内科,上海 200233)])]), Author(id=1329869471797326129, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329869471868629299, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, authorId=1329869471797326129, language=EN, stringName=Niansong WANG, firstName=Niansong, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, *, address=
1.Department of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329869471935738164, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, authorId=1329869471797326129, language=CN, stringName=汪年松, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, *, address=
1.上海交通大学附属上海市第六人民医院肾脏内科,上海 200233, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329869471281426719, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, xref=1., ext=[AuthorCompanyExt(id=1329869471289815328, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, companyId=1329869471281426719, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.Department of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China), AuthorCompanyExt(id=1329869471298203937, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, companyId=1329869471281426719, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.上海交通大学附属上海市第六人民医院肾脏内科,上海 200233)])])], keywords=[Keyword(id=1329869472078344502, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, language=EN, orderNo=1, keyword=sodium-glucose linked transporter 2 inhibitor), Keyword(id=1329869472145453367, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, language=EN, orderNo=2, keyword=diabetic nephropathy), Keyword(id=1329869472204173624, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, language=EN, orderNo=3, keyword=mechanism of action), Keyword(id=1329869472275476793, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, language=EN, orderNo=4, keyword=renal protection), Keyword(id=1329869472342585658, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, language=EN, orderNo=5, keyword=cardiac protection), Keyword(id=1329869472401305915, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, language=CN, orderNo=1, keyword=钠-葡萄糖耦联转运体2抑制剂), Keyword(id=1329869472460026172, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, language=CN, orderNo=2, keyword=糖尿病肾病), Keyword(id=1329869472522940733, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, language=CN, orderNo=3, keyword=作用机制), Keyword(id=1329869472581660990, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, language=CN, orderNo=4, keyword=肾脏保护), Keyword(id=1329869472644575551, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, language=CN, orderNo=5, keyword=心脏保护)], refs=[Reference(id=1329869472887845186, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Cheng HT, Xu X, Lim PS,
et al. Worldwide epidemiology of diabetes-related end-stage renal disease, 2000—2015[J]. Diabetes Care, 2021.44(1): 89-97., articleTitle=null, refAbstract=null), Reference(id=1329869472950759747, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Huang W, Chen YY, Li ZQ,
et al. Recent advances in the emerging therapeutic strategies for diabetic kidney diseases[J]. Int J Mol Sci, 2022, 23(18): 10882., articleTitle=null, refAbstract=null), Reference(id=1329869473013674308, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Barrera-Chimal J, Lima-Posada I, Bakris GL,
et al. Mineralocorticoid receptor antagonists in diabetic kidney disease-mechanistic and therapeutic effects[J]. Nat Rev Nephrol, 2022, 18(1): 56-70., articleTitle=null, refAbstract=null), Reference(id=1329869473084977477, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Shao S, Zhang X, Xu Q,
et al. Emerging roles of glucagon like peptide-1 in the management of autoimmune diseases and diabetes-associated comorbidities[J]. Pharmacol Ther, 2022, 239: 108270., articleTitle=null, refAbstract=null), Reference(id=1329869473147892038, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Wilcox CS. Antihypertensive and renal mechanisms of SGLT2 (sodium-glucose linked transporter 2) inhibitors[J]. Hypertension, 2020, 75(4): 894-901., articleTitle=null, refAbstract=null), Reference(id=1329869473206612295, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Thomas MC, Cherney DZI. The actions of SGLT2 inhibitors on metabolism, renal function and blood pressure[J]. Diabetologia, 2018, 61(10): 2098-2107., articleTitle=null, refAbstract=null), Reference(id=1329869473265332552, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Vallon V, Thomson SC. Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition[J]. Diabetologia, 2017, 60(2): 215-225., articleTitle=null, refAbstract=null), Reference(id=1329869473336635721, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Vaduganathan M, Inzucchi SE, Sattar N,
et al. Effects of empagliflozin on insulin initiation or intensification in patients with type 2 diabetes and cardiovascular disease: findings from the EMPA-REG outcome trial[J]. Diabetes Obes Metab, 2021, 23(12): 2775-2784., articleTitle=null, refAbstract=null), Reference(id=1329869473403744586, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Hu S, Lin C, Cai X,
et al. The urinary glucose excretion by sodium-glucose cotransporter 2 inhibitor in patients with different levels of renal function: a systematic review and meta-analysis[J]. Front Endocrinol (Lausanne), 2022, 12: 814074., articleTitle=null, refAbstract=null), Reference(id=1329869473521185099, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Georgianos PI, Agarwal R. Ambulatory blood pressure reduction with SGLT-2 inhibitors: dose-response meta-analysis and comparative evaluation with low-dose hydrochlorothiazide[J]. Diabetes Care, 2019, 42(4): 693-700., articleTitle=null, refAbstract=null), Reference(id=1329869473592488268, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Dimova R, Tankova T. Does SGLT2 inhibition affect sympathetic nerve activity in type 2 diabetes?[J]. Horm Metab Res, 2021, 53(2): 75-84., articleTitle=null, refAbstract=null), Reference(id=1329869473663791437, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Salvatore T, Galiero R, Caturano A,
et al. An overview of the cardiorenal protective mechanisms of SGLT2 inhibitors[J]. Int J Mol Sci, 2022.23(7): 3651., articleTitle=null, refAbstract=null), Reference(id=1329869473735094606, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Wang J, Chen Y, Xu W,
et al. Effects of intensive blood pressure lowering on mortality and cardiovascular and renal outcomes in type 2 diabetic patients: a meta-analysis[J]. PLoS One, 2019, 14(4): e0215362., articleTitle=null, refAbstract=null), Reference(id=1329869473806397775, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Wang H, Yang J, Chen X,
et al. Effects of sodium-glucose cotransporter 2 inhibitor monotherapy on weight changes in patients with type 2 diabetes mellitus: a Bayesian network meta-analysis[J]. Clin Ther, 2019, 41(2): 322-334., articleTitle=null, refAbstract=null), Reference(id=1329869473881895248, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Novikov A, Fu Y, Huang W,
et al. SGLT2 inhibition and renal urate excretion: role of luminal glucose, GLUT9, and URAT1[J]. Am J Physiol Renal Physiol, 2019, 316(1): F173-F185., articleTitle=null, refAbstract=null), Reference(id=1329869473949004113, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Calapkulu M, Cander S, Gul OO,
et al. Lipid profile in type 2 diabetic patients with new dapagliflozin treatment; actual clinical experience data of six months retrospective lipid profile from single center[J]. Diabetes Metab Syndr, 2019, 13(2): 1031-1034., articleTitle=null, refAbstract=null), Reference(id=1329869474011918674, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Szekeres Z, Toth K, Szabados E. The effects of SGLT2 inhibitors on lipid metabolism[J]. Metabolites, 2021, 11(2): 87., articleTitle=null, refAbstract=null), Reference(id=1329869474196468051, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Sánchez-García A, Simental-Mendía M, Millán-Alanís JM,
et al. Effect of sodium-glucose co-transporter 2 inhibitors on lipid profile: a systematic review and meta-analysis of 48 randomized controlled trials[J]. Pharmacol Res, 2020, 160: 105068., articleTitle=null, refAbstract=null), Reference(id=1329869474280354132, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Alicic RZ, Neumiller JJ, Johnson EJ,
et al. Sodium-glucose cotransporter 2 inhibition and diabetic kidney disease[J]. Diabetes, 2019, 68(2): 248-257., articleTitle=null, refAbstract=null), Reference(id=1329869474355851605, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Kidokoro K, Cherney DZI, Bozovic A,
et al. Evaluation of glomerular hemodynamic function by empagliflozin in diabetic mice using
in vivo imaging[J]. Circulation, 2019, 140(4): 303-315., articleTitle=null, refAbstract=null), Reference(id=1329869474427154774, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Silva Dos Santos D, Polidoro JZ, Borges-Júnior FA,
et al. Cardioprotection conferred by sodium-glucose cotransporter 2 inhibitors: a renal proximal tubule perspective[J]. Am J Physiol Cell Physiol, 2020, 318(2): C328-C336., articleTitle=null, refAbstract=null), Reference(id=1329869474498457943, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Burns KD, Cherney D. Renal angiotensinogen and sodium-glucose cotransporter-2 inhibition: insights from experimental diabetic kidney disease[J]. Am J Nephrol, 2019, 49(4): 328-330., articleTitle=null, refAbstract=null), Reference(id=1329869474578149720, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Puglisi S, Rossini A, Poli R,
et al. Effects of SGLT2 inhibitors and GLP-1 receptor agonists on renin-angiotensin-aldosterone system[J]. Front Endocrinol (Lausanne), 2021, 12: 738848., articleTitle=null, refAbstract=null), Reference(id=1329869474649452889, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Sawamura T, Karashima S, Nagase S,
et al. Effect of sodium-glucose cotransporter-2 inhibitors on aldosterone-to-renin ratio in diabetic patients with hypertension: a retrospective observational study[J]. Bio Med Central Endocr Disord, 2020, 20(1): 177., articleTitle=null, refAbstract=null), Reference(id=1329869474724950362, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Hesp AC, Schaub JA, Prasad PV,
et al. The role of renal hypoxia in the pathogenesis of diabetic kidney disease: a promising target for newer renoprotective agents including SGLT2 inhibitors?[J]. Kidney Int, 2020, 98(3): 579-589., articleTitle=null, refAbstract=null), Reference(id=1329869474854973787, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Ravindran S, Munusamy S. Renoprotective mechanisms of sodium-glucose co-transporter 2 (SGLT2) inhibitors against the progression of diabetic kidney disease[J]. J Cell Physiol, 2022, 237(2): 1182-1205., articleTitle=null, refAbstract=null), Reference(id=1329869474926276956, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Inoue MK, Matsunaga Y, Nakatsu Y,
et al. Possible involvement of normalized Pin1 expression level and AMPK activation in the molecular mechanisms underlying renal protective effects of SGLT2 inhibitors in mice[J]. Diabetol Metab Syndr, 2019, 11: 57., articleTitle=null, refAbstract=null), Reference(id=1329869474993385821, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Hattori Y. Beneficial effects on kidney during treatment with sodium-glucose cotransporter 2 inhibitors: proposed role of ketone utilization[J]. Heart Fail Rev, 2021, 26(4): 947-952., articleTitle=null, refAbstract=null), Reference(id=1329869475077271902, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=Lee YH, Kim SH, Kang JM,
et al. Empagliflozin attenuates diabetic tubulopathy by improving mitochondrial fragmentation and autophagy[J]. Am J Physiol Renal Physiol, 2019, 317(4): F767-F780., articleTitle=null, refAbstract=null), Reference(id=1329869475144380767, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=Korbut AI, Taskaeva IS, Bgatova NP,
et al. SGLT2 inhibitor empagliflozin and DPP4 inhibitor linagliptin reactivate glomerular autophagy in db/db mice, a model of type 2 diabetes[J]. Int J Mol Sci, 2020, 21(8): 2987., articleTitle=null, refAbstract=null), Reference(id=1329869475219878240, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=Cassis P, Locatelli M, Cerullo D,
et al. SGLT2 inhibitor dapagliflozin limits podocyte damage in proteinuric nondiabetic nephropathy[J]. JCI Insight, 2018, 3(15): e98720., articleTitle=null, refAbstract=null), Reference(id=1329869475328930145, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=Maruyama T, Takashima H, Oguma H,
et al. Canagliflozin improves erythropoiesis in diabetes patients with anemia of chronic kidney disease[J]. Diabetes Technol Ther, 2019, 21(12): 713-720., articleTitle=null, refAbstract=null), Reference(id=1329869475408621922, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=Sano M, Goto S. Possible mechanism of hematocrit elevation by sodium glucose cotransporter 2 inhibitors and associated beneficial renal and cardiovascular effects[J]. Circulation, 2019, 139(17): 1985-1987., articleTitle=null, refAbstract=null), Reference(id=1329869475471536483, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=Ghanim H, Abuaysheh S, Hejna J,
et al. Dapagliflozin suppresses hepcidin and increases erythropoiesis[J]. J Clin Endocrinol Metab, 2020, 105(4): dgaa057., articleTitle=null, refAbstract=null), Reference(id=1329869475542839652, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=Perkovic V, Jardine MJ, Neal B,
et al. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy[J]. N Engl J Med, 2019, 380(24): 2295-2306., articleTitle=null, refAbstract=null), Reference(id=1329869475601559909, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=Jardine MJ, Zhou Z, Mahaffey KW,
et al. Renal, cardiovascular, and safety outcomes of canagliflozin by baseline kidney function: a secondary analysis of the CREDENCE randomized trial[J]. J Am Soc Nephrol, 2020, 31(5): 1128-1139., articleTitle=null, refAbstract=null), Reference(id=1329869475668668774, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=Heerspink HJL, Stefansson BV, Chertow GM,
et al. Rationale and protocol of the dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) randomized controlled trial[J]. Nephrol Dial Transplant, 2020, 35(2): 274-282., articleTitle=null, refAbstract=null), Reference(id=1329869475748360551, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=Heerspink HJL, Stefánsson BV, Correa-Rotter R,
et al. Dapagliflozin in patients with chronic kidney disease[J]. N Engl J Med, 2020, 383(15): 1436-1446., articleTitle=null, refAbstract=null), Reference(id=1329869475811275112, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=Wheeler DC, Stefansson BV, Batiushin M,
et al. The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics[J]. Nephrol Dial Transplant, 2020, 35(10): 1700-1711., articleTitle=null, refAbstract=null), Reference(id=1329869475903549801, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=Wiviott SD, Raz I, Bonaca MP,
et al. Dapagliflozin and cardiovascular outcomes in type 2 diabetes[J]. N Engl J Med, 2019, 380(4): 347-357., articleTitle=null, refAbstract=null), Reference(id=1329869475979047274, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=Cherney DZI, Charbonnel B, Cosentino F,
et al. Effects of ertugliflozin on kidney composite outcomes, renal function and albuminuria in patients with type 2 diabetes mellitus: an analysis from the randomised VERTIS CV trial[J]. Diabetologia, 2021, 64(6): 1256-1267., articleTitle=null, refAbstract=null), Reference(id=1329869476037767531, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=Cannon CP, Pratley R, Dagogo-Jack S,
et al. Cardiovascular outcomes with ertugliflozin in type 2 diabetes[J]. N Engl J Med, 2020, 383(15): 1425-1435., articleTitle=null, refAbstract=null), Reference(id=1329869476104876396, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=Heerspink HJL, Karasik A, Thuresson M,
et al. Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study[J]. Lancet Diabetes Endocrinol, 2020, 8(1): 27-35., articleTitle=null, refAbstract=null), Reference(id=1329869476184568173, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=Nagasu H, Yano Y, Kanegae H,
et al. Kidney outcomes associated with SGLT2 inhibitors versus other glucose-lowering drugs in real-world clinical practice: the Japan chronic kidney disease database[J]. Diabetes Care, 2021, 44(11): 2542-2551., articleTitle=null, refAbstract=null), Reference(id=1329869476255871342, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=Liu AYL, Low S, Yeoh E,
et al. A real-world study on SGLT2 inhibitors and diabetic kidney disease progression[J]. Clin Kidney J, 2022, 15(7): 1403-1414., articleTitle=null, refAbstract=null), Reference(id=1329869476360728943, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=Zelniker TA, Wiviott SD, Raz I,
et al. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials[J]. Lancet, 2019, 393(10166): 31-39., articleTitle=null, refAbstract=null), Reference(id=1329869476419449200, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=Neuen BL, Young T, Heerspink HJL,
et al. SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis[J]. Lancet Diabetes Endocrinol, 2019, 7(11): 845-854., articleTitle=null, refAbstract=null), Reference(id=1329869476473975153, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[48], rfOrder=47, authorNames=null, journalName=null, refType=null, unstructuredReference=Wang C, Zhou Y, Kong Z,
et al. The renoprotective effects of sodium-glucose cotransporter 2 inhibitors versus placebo in patients with type 2 diabetes with or without prevalent kidney disease: a systematic review and meta-analysis[J]. Diabetes Obes Metab, 2019, 21(4): 1018-1026., articleTitle=null, refAbstract=null), Reference(id=1329869476545278322, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[49], rfOrder=48, authorNames=null, journalName=null, refType=null, unstructuredReference=Petrie MC, Verma S, Docherty KF,
et al. Effect of dapagliflozin on worsening heart failure and cardiovascular death in patients with heart failure with and without diabetes[J]. J Am Med Assoc, 2020, 323(14): 1353-1368., articleTitle=null, refAbstract=null), Reference(id=1329869476608192883, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[50], rfOrder=49, authorNames=null, journalName=null, refType=null, unstructuredReference=Mcmurray JJV, Solomon SD, Inzucchi SE,
et al. Dapagliflozin in patients with heart failure and reduced ejection fraction[J]. N Engl J Med, 2019, 381(21): 1995-2008., articleTitle=null, refAbstract=null), Reference(id=1329869476683690356, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[51], rfOrder=50, authorNames=null, journalName=null, refType=null, unstructuredReference=Snaith JR, Holmes-Walker DJ, Greenfield JR. Reducing type 1 diabetes mortality: role for adjunctive therapies?[J]. Trends Endocrinol Metab, 2020, 31(2): 150-164., articleTitle=null, refAbstract=null), Reference(id=1329869476763382133, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[52], rfOrder=51, authorNames=null, journalName=null, refType=null, unstructuredReference=Danne T, Garg S, Peters AL,
et al. International consensus on risk management of diabetic ketoacidosis in patients with type 1 diabetes treated with sodium-glucose cotransporter (SGLT) inhibitors[J]. Diabetes Care, 2019, 42(6): 1147-1154., articleTitle=null, refAbstract=null), Reference(id=1329869476838879606, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[53], rfOrder=52, authorNames=null, journalName=null, refType=null, unstructuredReference=Groop PH, Dandona P, Phillip M,
et al. Effect of dapagliflozin as an adjunct to insulin over 52 weeks in individuals with type 1 diabetes: post-hoc renal analysis of the DEPICT randomised controlled trials[J]. Lancet Diabetes Endocrinol, 2020, 8(10): 845-854., articleTitle=null, refAbstract=null), Reference(id=1329869476922765687, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[54], rfOrder=53, authorNames=null, journalName=null, refType=null, unstructuredReference=Taylor SI, Blau JE, Rother KI,
et al. SGLT2 inhibitors as adjunctive therapy for type 1 diabetes: balancing benefits and risks[J]. Lancet Diabetes Endocrinol, 2019, 7(12): 949-958., articleTitle=null, refAbstract=null), Reference(id=1329869476985680248, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[55], rfOrder=54, authorNames=null, journalName=null, refType=null, unstructuredReference=Palanca A, Van Nes F, Pardo F,
et al. Real-world evidence of efficacy and safety of SGLT2 inhibitors as adjunctive therapy in adults with type 1 diabetes: a European two-center experience[J]. Diabetes Care, 2022, 45(3): 650-658., articleTitle=null, refAbstract=null), Reference(id=1329869477056983417, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[56], rfOrder=55, authorNames=null, journalName=null, refType=null, unstructuredReference=Pelletier R, Ng K, Alkabbani W,
et al. Adverse events associated with sodium glucose co-transporter 2 inhibitors: an overview of quantitative systematic reviews[J]. Ther Adv Drug Saf, 2021, 12: 2042098621989134., articleTitle=null, refAbstract=null), Reference(id=1329869477111509370, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[57], rfOrder=56, authorNames=null, journalName=null, refType=null, unstructuredReference=Garofalo C, Borrelli S, Liberti ME,
et al. SGLT2 inhibitors: nephroprotective efficacy and side effects[J]. Medicina (Kaunas), 2019.55(6): 268., articleTitle=null, refAbstract=null), Reference(id=1329869477174423931, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[58], rfOrder=57, authorNames=null, journalName=null, refType=null, unstructuredReference=Kamei J, Yamamoto S. Complicated urinary tract infections with diabetes mellitus[J]. J Infect Chemother, 2021, 27(8): 1131-1136., articleTitle=null, refAbstract=null), Reference(id=1329869477224755580, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[59], rfOrder=58, authorNames=null, journalName=null, refType=null, unstructuredReference=Arnott C, Huang Y, Neuen BL,
et al. The effect of canagliflozin on amputation risk in the CANVAS program and the CREDENCE trial[J]. Diabetes Obes Metab, 2020, 22(10): 1753-1766., articleTitle=null, refAbstract=null), Reference(id=1329869477291864445, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[60], rfOrder=59, authorNames=null, journalName=null, refType=null, unstructuredReference=Chang HY, Singh S, Mansour O,
et al. Association between sodium-glucose cotransporter 2 inhibitors and lower extremity amputation among patients with type 2 diabetes[J]. J Am Med Assoc Intern Med, 2018, 178(9): 1190-1198., articleTitle=null, refAbstract=null), Reference(id=1329869477354779006, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[61], rfOrder=60, authorNames=null, journalName=null, refType=null, unstructuredReference=American Diabetes Association. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2020[J]. Diabetes Care, 2020, 43(Suppl 1): S98-S202., articleTitle=null, refAbstract=null), Reference(id=1329869477438665087, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[62], rfOrder=61, authorNames=null, journalName=null, refType=null, unstructuredReference=American Diabetes Association Professional Practice Committee. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2022[J]. Diabetes Care, 2022, 45(Suppl 1): S125-S143., articleTitle=null, refAbstract=null), Reference(id=1329869477509968256, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[63], rfOrder=62, authorNames=null, journalName=null, refType=null, unstructuredReference=American Diabetes Association. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2019[J]. Diabetes Care, 2019, 42(Suppl 1): S90-S138., articleTitle=null, refAbstract=null), Reference(id=1329869477577077121, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[64], rfOrder=63, authorNames=null, journalName=null, refType=null, unstructuredReference=Cosentino F, Grant PJ, Aboyans V,
et al. 2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD[J]. Eur Heart J, 2020, 41(2): 255-323., articleTitle=null, refAbstract=null), Reference(id=1329869477648380290, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[65], rfOrder=64, authorNames=null, journalName=null, refType=null, unstructuredReference=中华医学会糖尿病学分会, 中华医学会内分泌学分会. 中国成人2型糖尿病合并心肾疾病患者降糖药物临床应用专家共识[J]. 中华内分泌代谢杂志, 2020, 36(6): 458-468., articleTitle=null, refAbstract=null), Reference(id=1329869477799375235, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[66], rfOrder=65, authorNames=null, journalName=null, refType=null, unstructuredReference=中华医学会糖尿病学分会微血管并发症学组. 中国糖尿病肾脏病防治指南(2021年版)[J]. 中华糖尿病杂志, 2021, 13(8): 762-784., articleTitle=null, refAbstract=null), Reference(id=1329869477929398660, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[67], rfOrder=66, authorNames=null, journalName=null, refType=null, unstructuredReference=中华医学会肾脏病学分会专家组. 糖尿病肾脏疾病临床诊疗中国指南[J]. 中华肾脏病杂志, 2021, 37(3): 255-304., articleTitle=null, refAbstract=null)], funds=[Fund(id=1329869472724267328, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, awardId=81770741; 81870504; 82270761, language=CN, fundingSource=国家自然基金面上项目(81770741; 81870504; 82270761), fundOrder=null, country=null), Fund(id=1329869472799764801, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, awardId=null, language=CN, fundingSource=上海市领军人才(058)资助, fundOrder=null, country=null)], companyList=[AuthorCompany(id=1329869471281426719, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, xref=1., ext=[AuthorCompanyExt(id=1329869471289815328, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, companyId=1329869471281426719, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.Department of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China), AuthorCompanyExt(id=1329869471298203937, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, companyId=1329869471281426719, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.上海交通大学附属上海市第六人民医院肾脏内科,上海 200233)]), AuthorCompany(id=1329869471356924194, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, xref=2., ext=[AuthorCompanyExt(id=1329869471365312803, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, companyId=1329869471356924194, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.Department of Nephrology, Putuo Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China), AuthorCompanyExt(id=1329869471373701412, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869470555812124, companyId=1329869471356924194, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.上海中医药大学附属普陀医院肾脏内科,上海 200062)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2023.01.004, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2023.01.004, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2023.01.004, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2023.01.004, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1673280000000, fullTextJson=null, articleText=null, reference=null)